Comprehensive Review of Mechanisms and Translational Perspectives on Programmed Cell Death in Vascular Calcification
Biomolecules · 21.11.2025 · 15 (12) · 1640
DOI: 10.3390/biom15121640 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 21.11.2025. Verfasst von Yiyang Cao und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Queen Mary School, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China. Hauptthemen laut MEDLINE: Vascular Calcification, Apoptosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, Health Commission of jiangxi province.
Abstract (Originalsprache)
Programmed cell death (PCD), a regulated cell death (RCD) subtype essential for physiological homeostasis, encompasses distinct mechanisms including apoptosis, necroptosis, autophagy, ferroptosis, cuproptosis, and pyroptosis. This evolutionarily conserved process critically regulates disease pathogenesis across degenerative disorders, malignancies, fungal infections, and vascular calcification (VC). VC manifests as pathological calcium deposition in cardiovascular tissues, impairing vascular elasticity and hemodynamics. These structural alterations elevate risks of atherosclerotic events, cerebrovascular accidents, and peripheral vascular dysfunction, while concomitantly inducing vital organ hypoperfusion and cardiac overload that predispose individuals to myocardial ischemia, left ventricular hypertrophy, and heart failure. Despite advances in delineating associated signaling networks, the molecular etiology of VC remains elusive, and effective therapeutic interventions are currently lacking. While systematically examining the pathophysiological contributions of both established and novel PCD mechanisms to VC progression, this review incorporates a discussion of cuproptosis as a novel form of PCD, which may serve as a target for atherosclerosis treatment. The inclusion of cuproptosis, alongside other PCD modalities, allows for a more integrated and updated perspective on the complex regulatory networks governing VC. Our objective is to synthesize the current understanding of how these diverse PCD pathways, both classical and emerging, collectively contribute to the disease pathogenesis and to explore the broader therapeutic potential of targeting PCD in VC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Queen Mary School, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China.
- School of Pharmacy, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China.
- Jiangxi Province Key Laboratory of Bioengineering Drugs, The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang Uni…
ORCID-Profile: Yiyang Cao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- Health Commission of jiangxi province
- the Jiangxi Province Key Laboratory of bioengineering drugs
Zitieren
APA
Cao, Y., Cao, Y., Liu, J., Ye, Y., & Jiang, M. (2025). Comprehensive Review of Mechanisms and Translational Perspectives on Programmed Cell Death in Vascular Calcification. Biomolecules, 15(12), 1640. https://doi.org/10.3390/biom15121640
Vancouver
Cao Y, Cao Y, Liu J, Ye Y, Jiang M. Comprehensive Review of Mechanisms and Translational Perspectives on Programmed Cell Death in Vascular Calcification. Biomolecules. 2025;15(12):1640. doi:10.3390/biom15121640
BibTeX
@article{Cao2025,
author = {Cao, Yiyang and Cao, Yulong and Liu, Jiaheng and Ye, Yifei and Jiang, Meixiu},
title = {Comprehensive Review of Mechanisms and Translational Perspectives on Programmed Cell Death in Vascular Calcification},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {12},
pages = {1640},
doi = {10.3390/biom15121640}
}
EUVIMED